GAMAMABS
Live / Registered — Registered (as of 08 Oct 2019)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86835146
- Registration number
- 5876999
- Mark type
- Stylized text
- Filed
- 01 Dec 2015
- Published for opposition
- 23 Jul 2019
- Registered
- 08 Oct 2019
- Attorney of record
- Jeffrey M. Goehring
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes
- Class 010 — Medical apparatus: Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease
- Class 042 — Scientific and technological services: Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases
Owner
- GamaMabs Pharma SA, Toulouse Cedex 1, FR
- GamaMabs Pharma SA, Toulouse Cedex 1, FR
- GamaMabs Pharma SA, Toulouse Cedex 1, FR
Prosecution history
- 08 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Mar 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 23 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2019 — PUBLISHED FOR OPPOSITION
- 03 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jun 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jun 2019 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 18 Jun 2019 — CASE RETURNED TO EXAMINATION
- 14 Jun 2019 — NOTICE OF ALLOWANCE CANCELLED
- 14 Jun 2019 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 14 Jun 2019 — ASSIGNED TO PETITION STAFF